Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 417

1.

PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study.

Hoyos-Ceballos GP, Ruozi B, Ottonelli I, Da Ros F, Vandelli MA, Forni F, Daini E, Vilella A, Zoli M, Tosi G, Duskey JT, López-Osorio BL.

Pharmaceutics. 2020 Jan 17;12(1). pii: E72. doi: 10.3390/pharmaceutics12010072.

2.

The Role of Biosimilars in Uveitis: Long-Term Real-World Outcomes of the Switch From Original to Biosimilar TNF-Alpha Inhibitors.

Fabiani C, Vitale A, Emmi G, Sgheri A, Lopalco G, Sota J, Guerriero S, Iannone F, Frediani B, Vannozzi L, Bianco MT, Giovannini V, Tosi GM, Cantarini L.

Front Pharmacol. 2019 Dec 9;10:1468. doi: 10.3389/fphar.2019.01468. eCollection 2019.

3.

Drug delivery across the blood-brain barrier: recent advances in the use of nanocarriers.

Mulvihill JJ, Cunnane EM, Ross AM, Duskey JT, Tosi G, Grabrucker AM.

Nanomedicine (Lond). 2020 Jan 9. doi: 10.2217/nnm-2019-0367. [Epub ahead of print]

PMID:
31916480
4.

The Peculiar Pattern of Type IV Collagen Deposition in Epiretinal Membranes.

Regoli M, Tosi GM, Neri G, Altera A, Orazioli D, Bertelli E.

J Histochem Cytochem. 2019 Dec 20:22155419897258. doi: 10.1369/0022155419897258. [Epub ahead of print]

PMID:
31858878
5.

Complexity in neuropsychological assessments of cognitive impairment: A network analysis approach.

Tosi G, Borsani C, Castiglioni S, Daini R, Franceschi M, Romano D.

Cortex. 2019 Nov 27;124:85-96. doi: 10.1016/j.cortex.2019.11.004. [Epub ahead of print]

PMID:
31846889
6.

Rewiring of Lipid Metabolism and Storage in Ovarian Cancer Cells after Anti-VEGF Therapy.

Curtarello M, Tognon M, Venturoli C, Silic-Benussi M, Grassi A, Verza M, Minuzzo S, Pinazza M, Brillo V, Tosi G, Ferrazza R, Guella G, Iorio E, Godfroid A, Sounni NE, Amadori A, Indraccolo S.

Cells. 2019 Dec 9;8(12). pii: E1601. doi: 10.3390/cells8121601.

7.

Treating juvenile idiopathic arthritis (JIA)-related uveitis beyond TNF-α inhibition: a narrative review.

Gaggiano C, Rigante D, Tosi GM, Vitale A, Frediani B, Grosso S, Fabiani C, Cantarini L.

Clin Rheumatol. 2019 Dec 10. doi: 10.1007/s10067-019-04763-3. [Epub ahead of print]

PMID:
31823144
8.

Nanoparticles as carriers for drug delivery of macromolecules across the blood-brain barrier.

Tosi G, Duskey JT, Kreuter J.

Expert Opin Drug Deliv. 2020 Jan;17(1):23-32. doi: 10.1080/17425247.2020.1698544. Epub 2019 Dec 3.

PMID:
31774000
9.

Molecular characterization of a Marek's disease virus strain detected in tumour-bearing turkeys.

Mescolini G, Lupini C, Davidson I, Massi P, Tosi G, Fiorentini L, Catelli E.

Avian Pathol. 2019 Nov 22:1-6. doi: 10.1080/03079457.2019.1691715. [Epub ahead of print]

PMID:
31702386
10.

Efficacy of monoclonal anti-tumour necrosis factor-α antibodies in uveitic macular oedema.

Tosi GM, Vitale A, Rigante D, Sota J, Emmi G, Lopalco G, Guerriero S, Iannone F, Vannozzi L, Bitossi A, Frediani B, Cantarini L, Fabiani C.

Clin Exp Rheumatol. 2019 Oct 17. [Epub ahead of print]

PMID:
31694738
11.

Nanomedicine Against Aβ Aggregation by β-Sheet Breaker Peptide Delivery: In Vitro Evidence.

Pederzoli F, Ruozi B, Duskey J, Hagmeyer S, Sauer AK, Grabrucker S, Coelho R, Oddone N, Ottonelli I, Daini E, Zoli M, Vandelli MA, Tosi G, Grabrucker AM.

Pharmaceutics. 2019 Nov 1;11(11). pii: E572. doi: 10.3390/pharmaceutics11110572.

12.

Use of anti-vascular endothelial growth factor drugs for eye disease in Tuscany: Development and test of indicators of treatment intensity.

Virgili G, Tosi GM, Figus M, Rizzo S, Murro V, Mucciolo DP, Roberto G, Gini R.

Eur J Ophthalmol. 2019 Oct 30:1120672119885045. doi: 10.1177/1120672119885045. [Epub ahead of print]

PMID:
31665917
13.

Vitreomacular interface alterations following peripheral laser retinopexy: Interface changes after laser.

Tosi GM, Bacci T, Tarantello A, Marigliani D, Calmanti G, Polito MS, Neri G, Fusco F, Cevenini G, Virgili G.

Eur J Ophthalmol. 2019 Sep 20:1120672119876547. doi: 10.1177/1120672119876547. [Epub ahead of print]

PMID:
31538489
14.

Effect of Chestnut Tannins and Short Chain Fatty Acids as Anti-Microbials and as Feeding Supplements in Broilers Rearing and Meat Quality.

Mannelli F, Minieri S, Tosi G, Secci G, Daghio M, Massi P, Fiorentini L, Galigani I, Lancini S, Rapaccini S, Antongiovanni M, Mancini S, Buccioni A.

Animals (Basel). 2019 Sep 5;9(9). pii: E659. doi: 10.3390/ani9090659.

15.

ROS-responsive "smart" polymeric conjugate: Synthesis, characterization and proof-of-concept study.

Oddone N, Pederzoli F, Duskey JT, De Benedictis CA, Grabrucker AM, Forni F, Angela Vandelli M, Ruozi B, Tosi G.

Int J Pharm. 2019 Oct 30;570:118655. doi: 10.1016/j.ijpharm.2019.118655. Epub 2019 Aug 31.

PMID:
31479731
16.

Marek's disease viruses circulating in commercial poultry in Italy in the years 2015-2018 are closely related by their meq gene phylogeny.

Mescolini G, Lupini C, Davidson I, Massi P, Tosi G, Catelli E.

Transbound Emerg Dis. 2020 Jan;67(1):98-107. doi: 10.1111/tbed.13327. Epub 2019 Aug 27.

PMID:
31411371
17.

The small GTPase Rab5c is a key regulator of trafficking of the CD93/Multimerin-2/β1 integrin complex in endothelial cell adhesion and migration.

Barbera S, Nardi F, Elia I, Realini G, Lugano R, Santucci A, Tosi GM, Dimberg A, Galvagni F, Orlandini M.

Cell Commun Signal. 2019 May 28;17(1):55. doi: 10.1186/s12964-019-0375-x.

18.

In vitro treatment of congenital disorder of glycosylation type Ia using PLGA nanoparticles loaded with GDP‑Man.

Bortot B, De Martino E, Tesser A, Ura B, Ruozi B, Aloisio M, Biffi S, Addobbati R, Tosi G, Dolcetta D, Severini GM.

Int J Mol Med. 2019 Jul;44(1):262-272. doi: 10.3892/ijmm.2019.4199. Epub 2019 May 16.

PMID:
31115488
19.

Targeting Brain Disease in MPSII: Preclinical Evaluation of IDS-Loaded PLGA Nanoparticles.

Rigon L, Salvalaio M, Pederzoli F, Legnini E, Duskey JT, D'Avanzo F, De Filippis C, Ruozi B, Marin O, Vandelli MA, Ottonelli I, Scarpa M, Tosi G, Tomanin R.

Int J Mol Sci. 2019 Apr 24;20(8). pii: E2014. doi: 10.3390/ijms20082014.

20.

Crenosoma vulpis in red foxes (Vulpes vulpes) in Northern Italy.

Morandi B, Bertaso S, Conboy G, Gustinelli A, Galuppi R, Tosi G, Poglayen G.

Parasitol Res. 2019 Jun;118(6):1981-1985. doi: 10.1007/s00436-019-06272-3. Epub 2019 Apr 11.

PMID:
30972572
21.

Nanomedicine in Alzheimer's disease: Amyloid beta targeting strategy.

Tosi G, Pederzoli F, Belletti D, Vandelli MA, Forni F, Duskey JT, Ruozi B.

Prog Brain Res. 2019;245:57-88. doi: 10.1016/bs.pbr.2019.03.001. Epub 2019 Apr 2. Review.

PMID:
30961872
22.

Efficacy and safety of certolizumab pegol and golimumab in the treatment of non-infectious uveitis.

Tosi GM, Sota J, Vitale A, Rigante D, Emmi G, Lopalco G, Guerriero S, Orlando I, Iannone F, Frediani B, Angotti R, Messina M, Galeazzi M, Vannozzi L, Cantarini L, Fabiani C.

Clin Exp Rheumatol. 2019 Jul-Aug;37(4):680-683. Epub 2019 Apr 3.

23.

Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study.

Bitossi A, Bettiol A, Silvestri E, Di Scala G, Bacherini D, Lopalco G, Venerito V, Iannone F, Vitale A, Tosi GM, Prisco D, Rizzo S, Fabiani C, Cantarini L, Virgili G, Vannozzi L, Emmi G.

Mediators Inflamm. 2019 Feb 10;2019:1623847. doi: 10.1155/2019/1623847. eCollection 2019.

24.

In Vitro Antimicrobial Activity of Essential Oils Against Salmonella enterica Serotypes Enteritidis and Typhimurium Strains Isolated from Poultry.

Ebani VV, Nardoni S, Bertelloni F, Tosi G, Massi P, Pistelli L, Mancianti F.

Molecules. 2019 Mar 4;24(5). pii: E900. doi: 10.3390/molecules24050900.

25.

Efficacy of anti-tumour necrosis factor-α monoclonal antibodies in patients with non-infectious anterior uveitis.

Fabiani C, Vitale A, Rigante D, Emmi G, Lopalco G, Sota J, Vannozzi L, Guerriero S, Bitossi A, Orlando I, Franceschini R, Frediani B, Galeazzi M, Iannone F, Tosi GM, Cantarini L.

Clin Exp Rheumatol. 2019 Mar-Apr;37(2):301-305. Epub 2019 Jan 18.

26.

Serum immunoglobulin D levels in patients with Behçet's disease according to different clinical manifestations.

Lucherini OM, Vitale A, Orlando I, Sota J, Fabiani C, Franceschini R, Simpatico A, Frediani B, Galeazzi M, Tosi GM, Cantarini L.

Clin Exp Rheumatol. 2018 Nov-Dec;36(6 Suppl 115):110-115. Epub 2018 Dec 12.

PMID:
30582507
27.

Epidemiological profile of non-infectious uveitis from the rheumatologist's perspective: a survey from two tertiary referral centres in Italy.

Lopalco G, Venerito V, Sota J, Rigante D, Guerriero S, Orlando I, Franceschini R, Favale R, Lapadula G, Castelli B, Frediani B, Galeazzi M, La Torre F, Iannone F, Tosi GM, Fabiani C, Cantarini L.

Clin Exp Rheumatol. 2018 Nov-Dec;36(6 Suppl 115):68-73. Epub 2018 Dec 12.

PMID:
30582503
28.

GI-16 lineage (624/I or Q1), there and back again: The history of one of the major threats for poultry farming of our era.

Franzo G, Cecchinato M, Tosi G, Fiorentini L, Faccin F, Tucciarone CM, Trogu T, Barbieri I, Massi P, Moreno A.

PLoS One. 2018 Dec 20;13(12):e0203513. doi: 10.1371/journal.pone.0203513. eCollection 2018.

29.

A study of quiet eye's phenomenon in the shooting section of "laser run" of modern pentathlon.

Chirico A, Fegatelli D, Galli F, Mallia L, Alivernini F, Cordone S, Giancamilli F, Pecci S, Tosi GM, Giordano A, Lucidi F, Massaro M.

J Cell Physiol. 2019 Jun;234(6):9247-9254. doi: 10.1002/jcp.27604. Epub 2018 Nov 15.

PMID:
30444003
30.

Long-term evaluation of corneal sub-basal nerve recovery after photorefractive keratectomy and influence of pars plana vitrectomy.

Tosi GM, Martone G, Bacci T, Tarantello A, Baiocchi S, Marigliani D, Cevenini G, Menicacci F, Virgili G, Massaro-Giordano G.

J Cell Physiol. 2019 May;234(5):7459-7466. doi: 10.1002/jcp.27504. Epub 2018 Nov 11.

PMID:
30417371
31.

The Controversial Role of TGF-β in Neovascular Age-Related Macular Degeneration Pathogenesis.

Tosi GM, Orlandini M, Galvagni F.

Int J Mol Sci. 2018 Oct 27;19(11). pii: E3363. doi: 10.3390/ijms19113363. Review.

32.

The Presence of Uveitis Is Associated with a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's Disease.

Fabiani C, Vitale A, Rigante D, Emmi G, Lopalco G, Di Scala G, Sota J, Orlando I, Franceschini R, Frediani B, Galeazzi M, Iannone F, Tosi GM, Cantarini L.

Ocul Immunol Inflamm. 2018 Aug 27:1-7. doi: 10.1080/09273948.2018.1511810. [Epub ahead of print]

PMID:
30148652
33.

Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients.

Fabiani C, Vitale A, Rigante D, Emmi G, Bitossi A, Lopalco G, Sota J, Guerriero S, Orlando I, Gentileschi S, Iannone F, Frediani B, Galeazzi M, Vannozzi L, Tosi GM, Cantarini L.

Clin Rheumatol. 2019 Feb;38(2):407-415. doi: 10.1007/s10067-018-4228-6. Epub 2018 Aug 11.

PMID:
30099655
34.

Correlation of Serum Amyloid-A Levels, Clinical Manifestations, Treatment, and Disease Activity in Patients with Behçet's Disease.

Sota J, Vitale A, Rigante D, Orlando I, Lucherini OM, Simpatico A, Lopalco G, Franceschini R, Galeazzi M, Frediani B, Fabiani C, Tosi GM, Cantarini L.

Isr Med Assoc J. 2018 Aug;20(8):517-521.

35.

Publisher Correction: TGF-β concentrations and activity are down-regulated in the aqueous humor of patients with neovascular age-related macular degeneration.

Tosi GM, Neri G, Caldi E, Fusco F, Bacci T, Tarantello A, Nuti E, Marigliani D, Baiocchi S, Traversi C, Barbarino M, Eandi CM, Parolini B, Mundo L, Santucci A, Orlandini M, Galvagni F.

Sci Rep. 2018 Jun 29;8(1):10141. doi: 10.1038/s41598-018-28203-5.

36.

Corneal Subbasal Nerve Density and Sensitivity After Pars Plana Vitrectomy Using Contact or Noncontact Wide-Angle Viewing Systems.

Tosi GM, Bacci T, Tarantello A, Martone G, Traversi C, Marigliani D, Cevenini G, Virgili G.

Cornea. 2018 Sep;37(9):1130-1137. doi: 10.1097/ICO.0000000000001656.

PMID:
29894320
37.

TGF-β concentrations and activity are down-regulated in the aqueous humor of patients with neovascular age-related macular degeneration.

Tosi GM, Neri G, Caldi E, Fusco F, Bacci T, Tarantello A, Nuti E, Marigliani D, Baiocchi S, Traversi C, Barbarino M, Eandi CM, Parolini B, Mundo L, Santucci A, Orlandini M, Galvagni F.

Sci Rep. 2018 May 23;8(1):8053. doi: 10.1038/s41598-018-26442-0. Erratum in: Sci Rep. 2018 Jun 29;8(1):10141.

38.

Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study.

Sota J, Vitale A, Insalaco A, Sfriso P, Lopalco G, Emmi G, Cattalini M, Manna R, Cimaz R, Priori R, Talarico R, de Marchi G, Frassi M, Gallizzi R, Soriano A, Alessio M, Cammelli D, Maggio MC, Gentileschi S, Marcolongo R, La Torre F, Fabiani C, Colafrancesco S, Ricci F, Galozzi P, Viapiana O, Verrecchia E, Pardeo M, Cerrito L, Cavallaro E, Olivieri AN, Paolazzi G, Vitiello G, Maier A, Silvestri E, Stagnaro C, Valesini G, Mosca M, de Vita S, Tincani A, Lapadula G, Frediani B, De Benedetti F, Iannone F, Punzi L, Salvarani C, Galeazzi M, Angotti R, Messina M, Tosi GM, Rigante D, Cantarini L; “Working Group” of Systemic Autoinflammatory Diseases of SIR (Italian Society of Rheumatology).

Clin Rheumatol. 2018 Aug;37(8):2233-2240. doi: 10.1007/s10067-018-4119-x. Epub 2018 May 17.

PMID:
29770930
39.

Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies.

Fabiani C, Sota J, Rigante D, Vitale A, Emmi G, Lopalco G, Vannozzi L, Guerriero S, Bitossi A, Orlando I, Franceschini R, Frediani B, Galeazzi M, Iannone F, Tosi GM, Cantarini L.

Clin Rheumatol. 2018 Oct;37(10):2805-2809. doi: 10.1007/s10067-018-4133-z. Epub 2018 May 15.

PMID:
29766375
40.

The eye involvement in monogenic autoinflammatory diseases: literature review and update.

Sota J, Vitale A, Fabiani C, Frediani B, Rigante D, Tosi GM, Zannin ME, Cantarini L.

Clin Exp Rheumatol. 2018 Jan-Feb;36 Suppl 110(1):44-53. Epub 2018 May 3. Review.

41.

Predictors of sustained clinical response in patients with Behçet's disease-related uveitis treated with infliximab and adalimumab.

Fabiani C, Vitale A, Rigante D, Emmi G, Lopalco G, Sota J, Vannozzi L, di Scala G, Guerriero S, Orlando I, Franceschini R, Capozzoli M, Frediani B, Galeazzi M, Iannone F, Tosi GM, Cantarini L.

Clin Rheumatol. 2018 Jun;37(6):1715-1720. doi: 10.1007/s10067-018-4092-4. Epub 2018 Apr 18.

PMID:
29671190
42.

Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis.

Fabiani C, Vitale A, Emmi G, Bitossi A, Lopalco G, Sota J, Guerriero S, Orlando I, Capozzoli M, Fusco F, Rana F, Iannone F, Frediani B, Galeazzi M, Vannozzi L, Tosi GM, Cantarini L.

Clin Rheumatol. 2019 Jan;38(1):63-70. doi: 10.1007/s10067-018-4069-3. Epub 2018 Apr 3.

PMID:
29611087
43.

Hybrid nanoparticles as a new technological approach to enhance the delivery of cholesterol into the brain.

Belletti D, Grabrucker AM, Pederzoli F, Menrath I, Vandelli MA, Tosi G, Duskey TJ, Forni F, Ruozi B.

Int J Pharm. 2018 May 30;543(1-2):300-310. doi: 10.1016/j.ijpharm.2018.03.061. Epub 2018 Mar 30.

PMID:
29608954
44.

Antioxidant activity and photostability assessment of trans-resveratrol acrylate microspheres.

Pignatello R, Pecora TMG, Cutuli GG, Catalfo A, De Guidi G, Ruozi B, Tosi G, Cianciolo S, Musumeci T.

Pharm Dev Technol. 2019 Feb;24(2):222-234. doi: 10.1080/10837450.2018.1455697. Epub 2018 Apr 6.

PMID:
29565215
45.

Neonatal Fc receptor is involved in the protection of fibrinogen after its intake in peripheral blood mononuclear cells.

Alberio T, Forlani G, Lualdi M, Tosi G, Accolla RS, Fasano M.

J Transl Med. 2018 Mar 14;16(1):64. doi: 10.1186/s12967-018-1446-2.

46.

Fowlpoxvirus recombinants coding for the CIITA gene increase the expression of endogenous MHC-II and Fowlpox Gag/Pro and Env SIV transgenes.

Bissa M, Forlani G, Zanotto C, Tosi G, De Giuli Morghen C, Accolla RS, Radaelli A.

PLoS One. 2018 Jan 31;13(1):e0190869. doi: 10.1371/journal.pone.0190869. eCollection 2018.

47.

Mirror Box Training in Hemiplegic Stroke Patients Affects Body Representation.

Tosi G, Romano D, Maravita A.

Front Hum Neurosci. 2018 Jan 4;11:617. doi: 10.3389/fnhum.2017.00617. eCollection 2017.

48.

Qualitative and semiquantitative analysis of the protein coronas associated to different functionalized nanoparticles.

Pederzoli F, Tosi G, Genovese F, Belletti D, Vandelli MA, Ballestrazzi A, Forni F, Ruozi B.

Nanomedicine (Lond). 2018 Feb;13(4):407-422. doi: 10.2217/nnm-2017-0250. Epub 2018 Jan 18.

PMID:
29345202
49.

Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery.

Vilella A, Belletti D, Sauer AK, Hagmeyer S, Sarowar T, Masoni M, Stasiak N, Mulvihill JJE, Ruozi B, Forni F, Vandelli MA, Tosi G, Zoli M, Grabrucker AM.

J Trace Elem Med Biol. 2018 Sep;49:210-221. doi: 10.1016/j.jtemb.2017.12.006. Epub 2017 Dec 27.

PMID:
29325805
50.

Monitoring of ochratoxin A and ochratoxin-producing fungi in traditional salami manufactured in Northern Italy.

Merla C, Andreoli G, Garino C, Vicari N, Tosi G, Guglielminetti ML, Moretti A, Biancardi A, Arlorio M, Fabbi M.

Mycotoxin Res. 2018 May;34(2):107-116. doi: 10.1007/s12550-017-0305-y. Epub 2018 Jan 3.

PMID:
29299825

Supplemental Content

Support Center